GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » Equity-to-Asset

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Equity-to-Asset : 0.86 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Shanxi Zhendong Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥5,118 Mil. Shanxi Zhendong Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥5,984 Mil. Therefore, Shanxi Zhendong Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.86.

The historical rank and industry rank for Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

SZSE:300158' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44   Med: 0.75   Max: 0.86
Current: 0.86

During the past 13 years, the highest Equity to Asset Ratio of Shanxi Zhendong Pharmaceutical Co was 0.86. The lowest was 0.44. And the median was 0.75.

SZSE:300158's Equity-to-Asset is ranked better than
89.32% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs SZSE:300158: 0.86

Shanxi Zhendong Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co Equity-to-Asset Chart

Shanxi Zhendong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 0.74 0.80 0.80 0.84

Shanxi Zhendong Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.85 0.85 0.84 0.86

Competitive Comparison of Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset falls into.



Shanxi Zhendong Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Shanxi Zhendong Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=5178.857/6180.497
=0.84

Shanxi Zhendong Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=5117.733/5984.488
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanxi Zhendong Pharmaceutical Co  (SZSE:300158) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Shanxi Zhendong Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Shanxi Zhendong Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Business Description

Traded in Other Exchanges
N/A
Address
Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100
Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.
Executives
Miao Hui Director
Ma Shi Feng Executives
Li Zhi Xu Executives
Li Xi Hai Director
You Rong Li Executives
Wang Xu Wen Executives
Dong Mi Zhu Directors, executives
Li Ren Hu Supervisors
Ning Lu Hong Directors, executives
Wang Li Qing Supervisors
Jin Zhi Xiang Supervisors

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Headlines

No Headlines